SuperGen's Kinase Inhibitors Prohibit Cancer Cell Proliferation
Posted on: Tuesday, 11 December 2007, 15:00 CST
US-based SuperGen has reported that its lead JAK2 kinase inhibitors prevented cancer cell proliferation in non-clinical models.
Testing of the lead candidates in treated leukemia cell cultures indicated that the JAK2 kinase inhibitors were active against both wild-type and mutant JAK2 kinase activity and caused potent inhibition of cancer cell proliferation.
Gregory Berk, chief medical officer of SuperGen, said: "The in vitro inhibition of cancer cell proliferation by our lead JAK2 kinase inhibitors demonstrates the promise that this program holds to treat both hematological cancers and solid tumors."
Source: Datamonitor
Related Articles
- Protein Can Help Cells Or Cause Cancer
- Cancer Stem Cells Generated By Cancer Outgrowth
- SuperGen's JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation
- Data Indicate That SuperGen's Lead JAK2 Kinase Inhibitors Prevent Cancer Cell Proliferation in Non-Clinical Models
- Invitrogen Exclusively Licenses Novel Click Chemistry-Based Cell Proliferation Assays From Harvard University
- Data Show Geron's Telomerase Inhibitor Cancer Drug is Active Against Cancer Stem Cells From Multiple Myeloma Patients
- Ultrasound Stimulation of Tendon Cell Proliferation and Upregulation of Proliferating Cell Nuclear Antigen
- Dietary Isothiocyanates Inhibit Caco-2 Cell Proliferation and Induce G^Sub 2^/M Phase Cell Cycle Arrest, DNA Damage, and G^Sub 2^/M Checkpoint Activation1
- Polytechnic University of Marche; Protein cross-talk regulates mesothelial cancer cell proliferation
Rating: 2.1 / 5 (7 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds